The ORENCIA® (abatacept) Promise Program™

The ORENCIA Promise Program – Program Terms

Eligibility

• Patient must:
  • be new* to treatment with ORENCIA.
  • be an appropriate patient for treatment of RA with ORENCIA.
  • currently have private health insurance that covers medication costs for ORENCIA.
  • not be participating in Medicare, Medicaid, TRICARE, VA, or other federally funded healthcare programs.
  • not be a resident of Massachusetts.

*Patient must not currently be taking ORENCIA and must have not taken ORENCIA in the past 6 months.

Terms and Conditions

• Enrollment in The ORENCIA Promise Program will be accepted until December 31, 2009.
• This program covers the cost of the ORENCIA copay only, not the cost of the infusion.
• Patient must be enrolled in the program before starting his or her first infusion with ORENCIA. If a patient has enrolled in the program and has not received his or her first infusion within 2 months from the time of enrollment, the patient may be discontinued from the program.
• An essential part of this program is complying with the infusion schedule. Bristol-Myers Squibb (BMS) reserves the right to discontinue reimbursement and terminate program benefits if a patient does not receive 3 infusions of ORENCIA during the first 6 weeks of therapy, unless patient's physician can provide appropriate medical documentation for the missed or delayed infusions.
• Patients will receive up to $500 towards the first copay of a biologic medication for RA (Enbrel®, Humira®, Remicade®, Rituxan®, Kineret®) if they are not satisfied after 6 months of treatment on ORENCIA.
  • Patients must have received at least 6 infusions over the 6 months (26 weeks) to qualify for the copay of another RA biologic treatment (unless their physician can provide appropriate medical documentation explaining the missed doses).
  • Patient must contact 1-800-ORENCIA to confirm they are not satisfied with their ORENCIA treatment within 30 days from the end of their enrollment in The ORENCIA Promise Program.
  • Copay of another RA biologic treatment is only valid for the first dose of an RA biologic (defined above) received by the patient within 3 months from the end of their enrollment in The ORENCIA Promise Program.
  • Copay of another RA biologic treatment is not valid if the office and/or patient has enrolled in a copay program, for above-mentioned RA biologics, that provides copay benefit to the patient for their first starting dose following completion of The ORENCIA Promise Program.
  • Residents of Michigan are not eligible for the copay offer of another RA biologic treatment.
• Active copay cards are intended for use at participating healthcare provider offices, specialty pharmacies, or other alternate sites of infusion where MasterCard® debit cards are accepted.
• This offer may not be combined with any other coupon, discount, prescription savings card, free trial, or other offer.
• Void where prohibited by law. This offer is valid only in the United States (excluding Massachusetts) and Puerto Rico.
• This is a limited-time offer. BMS reserves the right to rescind, revoke, amend, or terminate this offer, or the program in its entirety, at any time.
• BMS reserves the right to audit to be sure all patients meet the rules of the program. If patient does not meet the requirements of the program, BMS may terminate enrollment.

Indication and Usage

ORENCIA® (abatacept) is a prescription medicine that reduces signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA), including those who have not been helped enough by other medicines for RA. ORENCIA may prevent further damage to your bones and joints and may help your ability to perform daily activities.

ORENCIA can also make your immune system less able to fight infections, so you may be more likely to get infections or any infection you have may get worse. It is important to tell your doctor if you think you have any infections.

Important Safety Information About ORENCIA® (abatacept)

Before you receive treatment with ORENCIA, a lyophilized powder for intravenous infusion, you should tell your doctor about all your medical conditions, including if you:

• have any kind of infection even if it is small (such as an open cut or sore) or an infection that is in your whole body (such as the flu).
• have an infection that will not go away or a history of infections that keep coming back.
• have had tuberculosis (TB), a positive skin test for TB, or if you recently have been in close contact with someone who has had TB. If you get any of the symptoms of TB (a dry cough that doesn't go away, weight loss, fever, night sweats), call your doctor right away. Before you start ORENCIA, your doctor may examine you for TB or perform a skin test.
• have or have had viral hepatitis. Before you use ORENCIA, your doctor may examine you for hepatitis.
• have a history of chronic obstructive pulmonary (lung) disease (COPD).
• are scheduled to have surgery.
• are allergic to any of the following ingredients in ORENCIA: abatacept, maltose, monobasic sodium phosphate, or sodium chloride for administration.
• recently received a vaccination or are scheduled for any vaccination. You should not take live vaccines if you are receiving ORENCIA.
• have diabetes and use a blood glucose monitor to check your sugar levels. The infusion of ORENCIA contains maltose, a sugar that can give falsely high blood glucose readings with some monitors on the day you receive your infusion. Your doctor may tell you to use a different way to monitor your blood sugar levels.
• are pregnant, planning to become pregnant, or are thinking about becoming pregnant. It is not known if ORENCIA can harm your unborn baby.
• are breast-feeding. You will need to decide to either breast-feed or receive treatment with ORENCIA, but not both.
• take any other kinds of medicine, including prescription and nonprescription medicines, vitamins, and herbal supplements.
• are taking other biologic medicines to treat RA such as: Enbrel® (etanercept),
  Humira® (adalimumab), Remicade® (infliximab), Kineret® (anakinra) or Rituxan® (rituximab). You may have a higher chance of getting a serious infection if you take ORENCIA with other biologic medicines.

Possible Side Effects of ORENCIA® (abatacept)

ORENCIA can cause serious side effects including:

• Serious infections. Patients receiving ORENCIA have a higher chance of getting infections including pneumonia, and other infections caused by viruses, bacteria, or fungi. Call your doctor immediately if you feel sick or get any of the following signs of infection: fever, feel very tired, cough, feel flu-like, or warm, red or painful skin.
• Allergic reactions. Allergic reactions can happen on the day of treatment or the day after receiving ORENCIA. Tell your doctor or get emergency medical help right away if you have hives, swollen face, eyelids, lips, tongue, throat, or trouble breathing.
• Cancer (malignancies). Certain kinds of cancer have been reported in patients receiving ORENCIA. It is not known if ORENCIA increases your chance of getting certain kinds of cancer.
• Vaccinations. You should not receive ORENCIA with certain types of vaccines. ORENCIA may cause some vaccinations to be less effective.
• Respiratory problems in patients with COPD. You may get certain respiratory problems more often if you receive ORENCIA and have COPD, including: worsened COPD, pneumonia, cough, or trouble breathing.

The more common side effects with ORENCIA are headache, upper respiratory tract infection, sore throat, and nausea.

• Please read the Patient Information in the Full Prescribing Information.
• Back to top